Key Takeaways
What Is the Best Medicine for Stress and Anxiety? It Depends on the Diagnosis
Asking what is the best medicine for stress and anxiety assumes a single answer exists, but stress on its own is not something medicines are tested or approved to treat. NIMH defines stress as the physical or mental response to an external cause, and notes that it generally goes away once the situation is resolved[1]. When stress becomes ongoing, the pattern is tracked as chronic stress.
Medicines enter the picture when stress meets criteria for a diagnosis: generalized anxiety disorder, PTSD, acute stress disorder or adjustment disorder. NIMH lists psychotherapy and medication as the two main treatments for anxiety and says many people benefit from a combination of the two[1].
The evidence differs sharply by diagnosis.
For generalized anxiety disorder, a 2019 Lancet network meta-analysis of 89 trials found duloxetine, pregabalin, venlafaxine and escitalopram were more effective than placebo with relatively good acceptability[3]. For PTSD, sertraline and paroxetine are the only FDA-approved drugs[4].
For adjustment disorder, a 2019 review found no clear recommendations on how best to treat it[5].
Adjustment disorder
A stress-related diagnosis in which emotional or behavioural symptoms begin in response to an identifiable stressor, within 3 months of it, and cause distress out of proportion to the stressor or significant impairment[5]. Under DSM-5, symptoms do not last more than six additional months after the stressor or its consequences have resolved[5].
Related Terms
Source: DSM-5 criteria as tabulated in O'Donnell et al., 2019
Is There a Medicine for Stress Itself?
No medicine is approved specifically for stress. NIMH separates the two states: stress is generally a response to an external cause, while anxiety is a persistent feeling of apprehension or dread that can continue even when there is no immediate threat[1]. The full comparison is in the difference between stress and anxiety.
NIMH flags a risk of an anxiety disorder when stress symptoms interfere with everyday life, cause avoidance or seem to be always present[1]. That threshold is closer to where drug trials begin, since they enroll outpatients with a diagnosed disorder[3].
The closest diagnosis to being overwhelmed by a specific life event is adjustment disorder. A 2018 systematic review of 29 treatment trials rated the quality of evidence for both psychological and drug treatments as low to very low[5]. A 2019 follow-up review by the same research group concluded that the lack of high-quality trials remains a serious concern[5].
Adjustment disorder is common in medical settings. A multisite study of consultation psychiatry services in the United States, Canada and Australia found it was diagnosed in 12% of psychiatric consultations[5].
What Medicine Helps After a Traumatic or Acute Stressful Event?
Researchers have tested whether a drug given soon after trauma can prevent acute stress disorder or PTSD. A 2015 Lancet Psychiatry meta-analysis pooled 15 studies of drugs given within the first month after a traumatic event, including beta-blockers, hydrocortisone and SSRIs[8].
Across all study types, drug treatment lowered the risk of PTSD or acute stress disorder (risk ratio 0.65), but the effect disappeared when only the 10 randomized trials were analyzed (risk ratio 0.69, with a confidence interval crossing 1)[8].
Hydrocortisone was the exception, reducing PTSD risk in five studies of 164 people (risk ratio 0.38)[8]. The authors noted that the small number of studies and their limited quality cast uncertainty on these effects[8].
Once PTSD is diagnosed, the evidence is firmer. The 2023 VA/DoD guideline recommends paroxetine, sertraline or venlafaxine on moderate-quality evidence, suggests prazosin only for PTSD-related nightmares, and recommends against benzodiazepines[4]. Therapy and medication options are compared in PTSD treatment options.
Share of U.S. benzodiazepine misuse done mainly to relax or relieve tension
In 2015-2016 national survey data, relaxing or relieving tension was the most common reason adults misused benzodiazepines, ahead of help with sleep (26.6%). The study authors suggest some misuse may reflect untreated symptoms among people with poor access to care.
"The most common reason for misuse overall was to relax or relieve tension"
When Stress Becomes an Anxiety Disorder, Which Medicines Rank Best?
When stress has turned into generalized anxiety disorder, the largest comparison is the 2019 Lancet network meta-analysis of 89 trials and 25,441 patients across 22 drugs[3]. Duloxetine, pregabalin, venlafaxine and escitalopram were more effective than placebo with relatively good acceptability[3].
Mirtazapine, sertraline, fluoxetine, buspirone and agomelatine also looked effective and well tolerated, but those findings rested on small samples[3]. Quetiapine had the largest effect on HAM-A scores yet was poorly tolerated, and paroxetine and benzodiazepines were effective but also poorly tolerated compared with placebo[3].
These medicines are slow to start. NIMH says antidepressants usually take 4 to 8 weeks to work, and buspirone must be taken every day for 3 to 4 weeks to reach its full effect[2]. Rankings by disorder are covered in what is the best medicine for anxiety, and the SSRI class in SSRIs for anxiety.
What About Fast-Acting Pills: Benzodiazepines, Hydroxyzine and Beta-Blockers?
NIMH describes benzodiazepines and beta-blockers as useful as needed to reduce severe anxiety in the short term, and notes that long-term benzodiazepine use may lead to tolerance or dependence[2].
In September 2020 the FDA required an updated Boxed Warning, its most prominent warning, for all benzodiazepines, covering abuse, misuse, addiction, physical dependence and withdrawal[9]. The agency said physical dependence can occur when benzodiazepines are taken steadily for several days to weeks, even as prescribed[9].
Use is widespread. In 2015-2016 survey data, an estimated 30.6 million U.S. adults (12.6%) used benzodiazepines in the past year, and misuse accounted for 17.2% of all use[6]. A friend or relative was the most common source of misused pills, supplying them free in 53.2% of cases[6].
Hydroxyzine, an antihistamine, has a thinner record. A 2010 Cochrane review of five studies with 884 participants found it more effective than placebo for generalized anxiety disorder, but the high risk of bias and small samples meant it could not be recommended as a reliable first-line treatment[10].
Beta-blockers such as propranolol are prescribed off-label for short-term anxiety symptoms, according to NIMH[2]. A 2025 systematic review found 10 eligible studies and no evidence of benefit over placebo or benzodiazepines in social phobia or panic disorder, while noting that beta-blocker prescribing for anxiety rose substantially from 2003 to 2018[7].
Do Supplements or Over-the-Counter Options Work for Stress?
Among supplements, ashwagandha has been tested for stress in pooled randomized trials. A 2022 meta-analysis of 12 randomized trials with 1,002 participants found it reduced both stress and anxiety scores compared with placebo, but rated the certainty of the evidence as low for both outcomes[11].
NCCIH says some ashwagandha preparations may be effective for insomnia and stress, while evidence on anxiety is unclear[12]. It describes ashwagandha as possibly safe for up to 3 months, links it to rare cases of liver injury, and says it should be avoided in pregnancy[12].
The pooled trials enrolled adults aged 25 to 48, so the results say little about teens or older adults[11]. Trial-by-trial detail is in ashwagandha for anxiety and supplements for anxiety.
How Does Medicine Compare With Therapy for Stress-Related Problems?
For stress-linked conditions without a strong drug signal, talk therapy carries much of the evidence. In adjustment disorder trials, face-to-face and virtual reality cognitive behavioural therapy both produced significantly greater improvement than a waitlist, though samples were very small[5].
For anxiety, NIMH describes psychotherapy and medication as the two main treatments and notes that many people benefit from both[1]. Approaches with the strongest trial records are reviewed in therapy for anxiety, and work-specific findings in how to cope with stress at work.
The evidence gap is widest for stress that is disruptive but short of a disorder. Adjustment disorder, the diagnosis that covers that zone, still lacks high-quality trials of any treatment[5].
Frequently Asked Questions
Sources & References
- National Institute of Mental Health. I'm So Stressed Out! Fact Sheet. National Institutes of Health. Published 2020. Accessed October 2026. https://www.nimh.nih.gov/health/publications/so-stressed-out-fact-sheet [Link]
- National Institute of Mental Health. Mental Health Medications. National Institutes of Health. Published 2023. Accessed October 2026. https://www.nimh.nih.gov/health/topics/mental-health-medications [Link]
- Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. The Lancet. Published 2019. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/30712879/ [Link]
- National Center for PTSD. Clinician's Guide to Medications for PTSD. U.S. Department of Veterans Affairs. Published 2025. Accessed October 2026. https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp [Link]
- O'Donnell ML, Agathos JA, Metcalf O, Gibson K, Lau W. Adjustment Disorder: Current Developments and Future Directions. International Journal of Environmental Research and Public Health. Published 2019. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC6678970/ [Link]
- Maust DT, Lin LA, Blow FC. Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatric Services. Published 2019. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ps.201800321 [Link]
- Archer C, Wiles N, Kessler D, Turner K, Caldwell DM. Beta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis. Journal of Affective Disorders. Published 2025. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/39271062/ [Link]
- Sijbrandij M, Kleiboer A, Bisson JI, Barbui C, Cuijpers P. Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis. The Lancet Psychiatry. Published 2015. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/26360285/ [Link]
- U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. U.S. Food and Drug Administration. Published 2020. Accessed October 2026. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class [Link]
- Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database of Systematic Reviews. Published 2010. Accessed October 2026. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006815.pub2/full [Link]
- Akhgarjand C, Asoudeh F, Bagheri A, et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research. Published 2022. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/36017529/ [Link]
- National Center for Complementary and Integrative Health. Ashwagandha: Usefulness and Safety. National Institutes of Health. Published 2023. Accessed October 2026. https://www.nccih.nih.gov/health/ashwagandha [Link]